Featured News
LuGENE® Lupus Test Launches to Predict Flares & Drug Targets
AMPEL BioSolutions’ Precision Medicine Breakthrough Predicts Drug Options with RNA Analytics & Machine Learning
Virginia Workforce Award to AMPEL BioSolutions
AMPEL on Bloomberg Markets
Lupus, coronary artery disease share genetic risk factors; data may lead to early testing
Innovator-of-Year to AMPEL
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
The question that today’s publication addresses with the multicenter, randomized, double-blind, placebo-controlled ORKIDS trial was whether inflammatory disease activity of people living with Lupus was influenced with a “food as medicine” approach of Omega3 Krill Oil supplementation.
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
Today AMPEL BioSolutions, with collaborators Lupus Therapeutics and Aker Biomarine, revealed peer-reviewed results that supplementation with Omega3-rich Krill Oil improves disease activity of autoimmune Lupus patients. Omega3 lipids
AMPEL BioSolutions Selected as Member of ARPA-H Customer Experience Hub Spoke Network
“We are thrilled to have our cutting-edge precision health technology for individuals and experience improving clinical trial outcomes included in the ARPA-H Experience Hub,” said Dr. Amrie Grammer, AMPEL’s President and Chief Scientific Officer.
Personalized Precision Medicine: AMPEL’s Tech Increases Clnical Trial Success
Dr. Amrie Grammer, co-founder of AMPEL BioSolutions, joins the show to discuss biotech and her company Hosted by Paul Sweeney and Matt Miller.
Reuters – Google Webinar Featuring AMPEL for Pharma Partnering
Reuters Events webinar with AMPEL, Google Cloud, Novartis, Asklepios and Pfizer to learn how data-driven innovation is reshaping clinical trials and paving the way towards faster drug discovery, more diverse patient enrolment and improved patient retention.
AMPEL’s AL/ML in Clinical Trial Design
Panel Presentation at the Precision Medical World Conference, June 29, 2022
Podcast on Lupus Diagnosis & Treatment
An Interview with Dr. Amrie Grammer on Dartmouth's "No Scrubs" Podcast
Cville Company Uses Genetics and Big Data to Find Better Medical Treatments
CLICK TO READ AND LISTEN TO ARTICLE > Getting approval for new drugs takes years and costs companies millions of dollars. What’s more, clinical trials sometimes fail, leaving firms with nothing to show. Now, however, a Virginia company is taking a different...